The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 9/Signature 2
From BugSigDB
< The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies | The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 9
Source: Figure 7
Description: Gut microbiome compositional differences in response to the initiation and continuation Levodopa-Carbidopa Intestinal gel (LCIG) therapies at 6months
Abundance in Group 1: decreased abundance in LCIG(Levodopa-Carbidopa Intestinal Gel)
| NCBI | Quality Control | Links |
|---|---|---|
| Acetanaerobacterium | ||
| Eggerthella | ||
| Gordonibacter | ||
| Hespellia | ||
| Holdemania |
Revision editor(s): Bolanle
